Chemsex

Editorial

By Pierre Poloméni

Chemsex: it’s time to act!

By Thomas L’Yavanc

Links between treatment, psychotherapy, and determining factors in problematic chemsex practices: An analysis based on clinical experience

By Muriel Grégoire

Chemsex practice in France: Updating addictovigilance data

By Anne Batisse, Leila Chaouachi, Johan Thiery, Anne Roussin, Cécile Chevalier, Anne-Sylvie Caous, Aurélie Aquizerate, Liselotte Pochard, Émilie Bouquet, Reynald Leboisselier, Amélie Daveluy, Célian Bertin, Bruno Revol, Hélène Peyrière

Chemsex practice in national surveys in France on relationships to sex among men who have sex with men: Developments between 2017 and 2023

By Annie Velter, Perrine Roux

An innovative therapeutic initiative: The implementation of a care pathway dedicated to chemsex in the infectious diseases department of Hôpital Saint-Louis

By Iris Bichard

Chemsex and sexuality: Characterizing vulnerability factors, patients’ needs and sexological approaches during a hospital intervention

By Alexandre Aslan, David Lessard, Bertrand Lebouché

Assessing the sexual health of men who have sex with men, attending addictology consultations in Montpellier for chemsex use

By Hélène Donnadieu, Marion Ambrosino

Chemsex in psychiatry: Systemic effects?

By Jean-Victor Blanc

Going through GBL withdrawal in hospital: Some case studies

By Dorian Rollet, Melody Moya, Julien Azuar, Frank Questel, Romain Icick

Using cannabis to manage consumption of other psychoactive substances: A questionnaire survey of people who use cannabis in France

By Martin Bastien, Fabienne Lopez, Pierre Chappard, Perrine Roux